Rajat Nandi

Silchar, AS, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Unveiling potent anti-leishmanial agents: a QSAR exploration of diverse chemical scaffolds targeting Leishmania donovani amastigotes.

Unveiling potent anti-leishmanial agents: a QSAR exploration of diverse chemical scaffolds targeting Leishmania donovani amastigotes.

Journal: SAR and QSAR in environmental research

Published: July 25, 2025

Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds.

Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds.

Journal: Molecular diversity

Published: October 22, 2024

Investigation of antileishmanial, antioxidant activities, CT-DNA interaction and DFT study of novel cobalt(II) complexes derived from mesogenic aromatic amino acids based Schiff base ligands.

Investigation of antileishmanial, antioxidant activities, CT-DNA interaction and DFT study of novel cobalt(II) complexes derived from mesogenic aromatic amino acids based Schiff base ligands.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: June 04, 2024

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.

Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.

Journal: Scientific reports

Published: October 07, 2023

Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.

Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.

Journal: Journal of biomolecular structure & dynamics

Published: August 30, 2021

Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.

Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.

Journal: Frontiers in pharmacology

Published: November 26, 2020

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.

Journal: Heliyon

Published: May 22, 2020

Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.

Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: May 06, 2020

Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches.

Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches.

Journal: Journal of biomolecular structure & dynamics

Published: March 07, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026